| Description | Talaporfin is a photosensitizer used in photodynamic therapy. |
| In vitro | Talaporfin is a photosensitizer used in photodynamic therapy. Talaporfin absorbs red light at 664 nm normally provided by a laser tuned to this wavelength. Talaporfin was approved in Japan (in 2004) for PDT of lung cancer and marketed as Laserphyrin [1][2]. |
| Synonyms | ME2906, 他拉泊芬钠, NPe6, Mono-L-aspartyl chlorin e6 |
| molecular weight | 734.762 |
| Molecular formula | C38H41N5NaO9 |
| CAS | 220201-34-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 2 mg/mL (2.50 mM), Sonication is recommended. H2O: 50 mg/mL (62.52 mM), Sonication is recommended. |
| References | 1. http://journals.lww.com/jto/Fulltext/2006/06000/Photodynamic_Therapy__PDT__for_Lung_Cancers.18.aspx 2. http://meeting.ascopubs.org/cgi/content/abstract/24/18_suppl/7229 |